BME News

January 19, 2016

Claridge receives NSF CAREER grant

Shelley Claridge, assistant professor of chemistry and assistant professor of biomedical engineering at the Weldon School of Biomedical Engineering, has received a Faculty Early Career Development (CAREER) grant from the National Science Foundation for her work titled, 'Standing, Lying, and Sitting: Restructuring Intermolecular Forces in Molecular Monolayers and Freshman Chemistry.'
January 19, 2016

Stephanie Thiede wins Pfizer Society of Toxicology Travel Award

A senior in the Weldon School of Biomedical Engineering at Purdue University has won a 2016 Pfizer Society of Toxicology (SOT) Undergraduate Student Travel Award. The organization recognized Stephanie N. Thiede as an outstanding undergraduate who will be presenting research in the field of toxicology at the society’s annual meeting. She will be formally honored by SOT at the awards ceremony during the Society’s 55th Annual Meeting and ToxExpo in New Orleans, Louisiana, March 13–17, 2016.
December 16, 2015

3 Purdue University professors elected as fellows of National Academy of Inventors

Three professors at the Weldon School of Biomedical Engineering at Purdue University have been named fellows of the National Academy of Inventors. The organization recognized Charles A. Bouman, the Showalter Professor of Electrical and Computer Engineering and Biomedical Engineering; Alyssa Panitch, vice provost for faculty affairs and the Leslie A. Geddes Professor of Biomedical Engineering; and Sherry L. Harbin, a professor of biomedical engineering and basic medical sciences.
December 10, 2015

Staff members honored for excellence

Congratulations to the 2015 Engineering Staff Awards of Excellence recipients and nominees. Eight Weldon School of Biomedical Engineering staff members were recognized for excellent service to the Purdue University College of Engineering in three award categories: administrative/professional customer service, leadership, and teamwork.
December 8, 2015

Symic secures $25 million in Series A-2 financing to advance clinical-stage biotherapeutics platform

Symic, a clinical-stage biotherapeutics company developing multiple compounds that target and affect the extracellular matrix (ECM), today announced that it has secured $25 million in a Series A-2 financing to advance the company's pipeline, including its lead candidates SB-030 and SB-061. The financing was led by Lilly Ventures and includes the participation by all existing major investors, as well as several new investors. This new funding brings the total capital raised by Symic to over $43 million since being founded in 2012.
November 24, 2015

Integrating a flipped lecture into a laboratory course

The flipped classroom model allows for active student learning by 'reversing' the traditional classroom structure. The content traditionally delivered inside the classroom (i.e. lectures) is recorded and provided to students online, while the in-class time is dedicated to identifying knowledge gaps and problem-solving.
November 24, 2015

New pain mechanisms revealed for neurotoxin in spinal cord injury

A toxin released by the body in response to spinal cord injuries increases pain by causing a proliferation of channels containing pain sensors, new research shows, and this hypersensitivity also extends to peripheral nerves in the limbs far from the injury site. Findings could point to a new route for treating pain in people with spinal cord injuries, said Riyi Shi (pronounced Ree Shee), a professor of neuroscience and biomedical engineering in Purdue University's Department of Basic Medical Sciences, College of Veterinary Medicine and Weldon School of Biomedical Engineering.
< Previous 10 | Viewing 841 to 850 of 1531 | Next 10 >